Ascenta Therapeutics ascenta.com


Public lists: Pharma Startups (4732)

Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta's current focus is a portfolio of orally-active, small molecule drugs that restore the natural potential for cancer cells to undergo cell death (apoptosis)

Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta's current focus is a portfolio of orally-active, small molecule drugs that resto...Show all

Company (Alive / Active)

Phone: 610-408-0301

Fax:

101 Lindenwood Drive
Suite 405
Malvern, 19355
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Ascenta Therapeutics $87.3M Feb 5, 2010
Threshold Pharmaceuticals $106.4M Aug 2, 2017
Trellis Bioscience $38.4M Nov 9, 2011
See all 23 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Ascenta Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Competitors

Company Status Description Investors
See all 23 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Process for preparing r-gossypol l-phenylalaninol dienamine Oct 01, 2008 Apr 13, 2010 Patent